Biswas, Asim
Loeffler, Kathryn
Kim, Donguk
Eisfeld, Amie J.
Duffy, Augustine
Hammond, Hunter
Sangappa, Anjali
Abozeid, Hassanein H.
Neumann, Gabriele
Moreno, Alberto
Kawaoka, Yoshihiro
Kane, Ravi S.
Funding for this research was provided by:
National Institutes of Health (R01 AI168408-01A1, R01 AI168408-01A1, R01 AI168408-01A1, R01 AI168408-01A1, R01 AI168408-01A1, R01 AI168408-01A1)
National Science Foundation (DGE-2039655, DGE-2039655)
National Institutes of Health, United States (T32 EB021962)
Article History
Received: 20 June 2025
Accepted: 11 September 2025
First Online: 3 November 2025
Competing interests
: The authors declare the following competing interests: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co., Ltd, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. Y.K. and G.N. are co-founders of FluGen. The remaining authors declare no competing interests.